President Trump Meets With Executives From The Pharmaceutical Industry In The Oval Office
WASHINGTON, DC - MAY 01: White House Press Secretary Kayleigh McEnany (L) and son-in-law and senior advisor to U.S. President Donald Trump Jared Kushner attend an announcement that the Food and Drug Administration issued an emergency approval for the antiviral drug remdesivir in the Oval Office at the White House May 01, 2020 in Washington, DC. A federal government trial found that patients with COVID-19 receiving Gilead Sciences' remdesivir recovered more quickly but the drug did not significantly reduce fatality rates. (Photo by Erin Schaff-Pool/Getty Images)
PURCHASE A LICENCE
How can I use this image?
475.00 €
EUR
DETAILS
Restrictions:
Contact your local office for all commercial or promotional uses. Full editorial rights UK, US, Ireland, Canada (not Quebec). Restricted editorial rights for daily newspapers elsewhere, please call.
Credit:
Editorial #:
1222297758
Collection:
Getty Images News
Date created:
01 May, 2020
Upload date:
Licence type:
Release info:
Not released. More information
Source:
Getty Images North America
Object name:
wh-10_2020050161225071.jpg
Max file size:
5941 x 3961 px (50.30 x 33.54 cm) - 300 dpi - 15 MB
- Jared Kushner,
- Oval Office,
- Remdesivir,
- Son-In-Law,
- Advice,
- Agreement,
- Attending,
- COVID-19,
- Death,
- Emergencies and Disasters,
- Finding,
- Food and Drug Administration,
- Gilead Sciences,
- Government,
- Healthcare And Medicine,
- Infectious Disease,
- International Landmark,
- Kayleigh McEnany,
- Pandemic - Illness,
- Patient,
- People,
- Politics,
- Politics and Government,
- Receiving,
- Recovery,
- Reduction,
- Senior Adult,
- Three Quarter Length,
- Two People,
- USA,
- Washington DC,
- White House Press Secretary,